MEDVi vs Mochi Health (2026): prices, structure, verdict

On tirzepatide, Mochi Health↗ is cheaper: $278 versus $399 a month all-in — a $121 monthly gap, $1,452 across a year of maintenance dosing.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

On semaglutide, Mochi Health is cheaper: $178 versus $299 a month all-in — a $121 monthly gap, $1,452 across a year of maintenance dosing.

§ Side by side

§ Each record, read aloud

The two records, condensed

MEDVi: the record, condensed

On tirzepatide, the number that matters at MEDVi is $399 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. It is a flat structure: 2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.

To place the number: #14 of 17 verified programs, with the floor $184/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $50 a month. A year at this figure: $4,788 monthly-billed.

On semaglutide, the number that matters at MEDVi is $299 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. The price is dose-flat: the standard titration ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.

Context for that figure: it ranks #18 of 20 in the verified semaglutide index — $166/month above the floor (Oak Longevity, $133) — and sits $50 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $3,588.

Operationally at MEDVi: shipping included; commitment 12-month plan for the lowest rate; cancellation 12-month plan applies to lowest rate; pharmacy not publicly named — ask in writing before paying; states: priced differently in CA/NC on some plans; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the MEDVi page · visit MEDVi ↗

Mochi Health: the record, condensed

Mochi Health’s tirzepatide program bills $278 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

The all-in figure already contains a compulsory $79 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $199 would be exactly that kind of mirage.

To place the number: #4 of 17 verified programs, with the floor $63/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $171 a month. A year at this figure: $3,336 monthly-billed.

Mochi Health’s semaglutide program bills $178 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at Mochi Health is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

The all-in figure already contains a compulsory $79 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $99 would be exactly that kind of mirage.

Context for that figure: it ranks #8 of 20 in the verified semaglutide index — $45/month above the floor (Oak Longevity, $133) — and sits $171 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $2,136.

Operationally at Mochi Health: shipping included; commitment membership recurs monthly; cancellation cancel membership any time; recurs until cancelled; pharmacy named (company-owned compounding facility); states: most states; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Mochi Health page · visit Mochi Health ↗

Tirzepatide: the duel in full

Put the two tirzepatide figures side by side and hold them there: Mochi Health at $278, MEDVi at $399 — a $121 monthly spread that compounds to $1,452 over a maintenance year and $2,904 over two.

Both figures are dose-flat, which is the cleanest possible comparison: two ceilings, no titration surprises on either side, and the $121 gap is exactly what it appears to be.

Mochi Health’s total includes a mandatory $79/month membership; MEDVi has none. The all-in figures above neutralize that difference — but the membership side has an exit consideration the other lacks: a fee that recurs until you affirmatively cancel it.

Semaglutide: the duel in full

The semaglutide arithmetic between these two is short: $178 (Mochi Health) against $299 (MEDVi). $121 a month sounds survivable; $1,452 a year is a decision.

Both figures are dose-flat, which is the cleanest possible comparison: two ceilings, no titration surprises on either side, and the $121 gap is exactly what it appears to be.

Mochi Health’s total includes a mandatory $79/month membership; MEDVi has none. The all-in figures above neutralize that difference — but the membership side has an exit consideration the other lacks: a fee that recurs until you affirmatively cancel it.

A way to feel the $121 monthly gap: over a year it funds 5.2 extra months at Mochi Health’s own rate — the difference is not decoration, it is medication. Over two years it compounds to $2,904, which is the horizon at which structural details (prepaid ladders, membership drag, dose-tier repricing) start mattering more than the sticker itself.

Run the same two programs on the committed basis: MEDVi $399/mo month-to-month against Mochi Health $278/mo month-to-month. The order holds: Mochi Health leads on both readings, so plan structure sharpens the verdict here rather than reversing it. Whichever basis fits your commitment level, the upfront totals above are the honest units.

§ The clock, run forward

Three, six, twelve, twenty-four months — best path each way

3 months: MEDVi $1,197 monthly; Mochi Health $834 monthly — best path favors Mochi Health by $363. 6 months: MEDVi $2,394 monthly; Mochi Health $1,668 monthly — best path favors Mochi Health by $726. 12 months: MEDVi $4,788 monthly; Mochi Health $3,336 monthly — best path favors Mochi Health by $1,452. 24 months: MEDVi $9,576 monthly; Mochi Health $6,672 monthly — best path favors Mochi Health by $2,904.

Prepaid paths above are billed upfront and assume the published rate holds (the 24-month figures extend the 12-month rate, an assumption worth naming). The honest reading: over short horizons the monthly gap decides; over long horizons the prepaid ladders and structural traps (dose tiers, memberships) take over — which is exactly the split the verdict section below scores.

The same clock, on semaglutide

3 mo: MEDVi $897 vs Mochi Health $534 — $363 to Mochi Health. 6 mo: MEDVi $1,794 vs Mochi Health $1,068 — $726 to Mochi Health. 12 mo: MEDVi $3,588 vs Mochi Health $2,136 — $1,452 to Mochi Health. 24 mo: MEDVi $7,176 vs Mochi Health $4,272 — $2,904 to Mochi Health.

Same rules as above: prepaid figures are upfront commitments, and the 24-month lines extend the 12-month rate as a stated assumption. Where the two molecules crown different winners between these two programs, that split is itself the finding — molecule choice and provider choice are separate decisions.

§ Structure vs structure

Everything besides the price

Coverage: MEDVi publishes “priced differently in CA/NC on some plans”; Mochi Health publishes “most states” — for anything short of an explicit 50-state claim, intake is the final word.

Pharmacy transparency splits them: Mochi Health names its network (company-owned compounding facility); MEDVi does not, which shifts the burden of verification onto your intake questions.

Exit terms: MEDVi — 12-month plan for the lowest rate; 12-month plan applies to lowest rate. Mochi Health — membership recurs monthly; cancel membership any time; recurs until cancelled.

Evidence: MEDVi source-verified (captured 2026-08-05); Mochi Health source-verified (2026-08-05).

The pattern worth internalizing: in this market, structural honesty and price honesty travel together. Programs that publish pharmacies and state lists tend to publish real maintenance prices; programs that hide one usually hide the other.

In the full tirzepatide index these two sit at #14 and #4 of 17: between them lie 9 other programs, and the whole ladder is at cheapest tirzepatide providers. In the full semaglutide index these two sit at #18 and #8 of 20: between them lie 9 other programs, and the whole ladder is at cheapest semaglutide providers.

§ If you move

Switching between MEDVi and Mochi Health

Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (MEDVi: 12-month plan applies to lowest rate; Mochi Health: cancel membership any time; recurs until cancelled) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.

§ Verdict by situation

Which one, for whom

§ More pairings